WO2003046213A3 - Procede pour concentrer et identifier des vih - Google Patents

Procede pour concentrer et identifier des vih Download PDF

Info

Publication number
WO2003046213A3
WO2003046213A3 PCT/EP2002/011931 EP0211931W WO03046213A3 WO 2003046213 A3 WO2003046213 A3 WO 2003046213A3 EP 0211931 W EP0211931 W EP 0211931W WO 03046213 A3 WO03046213 A3 WO 03046213A3
Authority
WO
WIPO (PCT)
Prior art keywords
concentrating
detecting hiv
viruses
detecting
lentiviruses
Prior art date
Application number
PCT/EP2002/011931
Other languages
German (de)
English (en)
Other versions
WO2003046213A2 (fr
Inventor
Uwe Michelsen
Achim Schwaemmle
Willi Roth
Original Assignee
Merck Patent Gmbh
Uwe Michelsen
Achim Schwaemmle
Willi Roth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh, Uwe Michelsen, Achim Schwaemmle, Willi Roth filed Critical Merck Patent Gmbh
Priority to AU2002351787A priority Critical patent/AU2002351787A1/en
Publication of WO2003046213A2 publication Critical patent/WO2003046213A2/fr
Publication of WO2003046213A3 publication Critical patent/WO2003046213A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne un procédé et un kit d'essai pour concentrer et identifier des lentivirus, notamment des VIH (virus d'immuno-déficience humaine), dans des échantillons biologiques complexes tels que des fluides corporels. Les virus sont liés à une phase solide dans des conditions appropriées, isolés, lysés, puis les acides nucléiques viraux sont séparés et éventuellement identifiés.
PCT/EP2002/011931 2001-11-26 2002-10-25 Procede pour concentrer et identifier des vih WO2003046213A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002351787A AU2002351787A1 (en) 2001-11-26 2002-10-25 Method for concentrating and detecting hiv

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10157624A DE10157624A1 (de) 2001-11-26 2001-11-26 Verfahren zur Anreicherung und zum Nachweis von HIV
DE10157624.2 2001-11-26

Publications (2)

Publication Number Publication Date
WO2003046213A2 WO2003046213A2 (fr) 2003-06-05
WO2003046213A3 true WO2003046213A3 (fr) 2003-10-02

Family

ID=7706795

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/011931 WO2003046213A2 (fr) 2001-11-26 2002-10-25 Procede pour concentrer et identifier des vih

Country Status (3)

Country Link
AU (1) AU2002351787A1 (fr)
DE (1) DE10157624A1 (fr)
WO (1) WO2003046213A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10258258A1 (de) * 2002-12-13 2004-06-24 Merck Patent Gmbh Verfahren zur Aufreinigung von Nukleinsäuren
WO2005093065A1 (fr) * 2004-03-16 2005-10-06 Roche Diagnostics Gmbh Methode amelioree d'isolement d'acides nucleiques
WO2006123781A1 (fr) * 2005-05-20 2006-11-23 Arkray, Inc. Procedes de recuperation de microorganisme et d’acide nucleique en utilisant une particule fine et necessaire a utiliser pour les procedes
DE102006032610C5 (de) * 2006-07-11 2016-09-15 Aj Innuscreen Gmbh Verfahren zur parallelen Isolierung viraler Nukleinsäuren
US10131935B2 (en) 2006-07-11 2018-11-20 Aj Innuscreen Gmbh Method for parallel isolation of viral nucleic acids

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234809A (en) * 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
US5681946A (en) * 1990-02-13 1997-10-28 Amersham International Plc Precipitating polymers
EP0897978A2 (fr) * 1997-08-22 1999-02-24 Becton, Dickinson and Company Oxyde de zirconium et de composés apparentés pour la purification des acides nucléiques
WO1999040098A1 (fr) * 1998-02-04 1999-08-12 Merck Patent Gmbh Procede pour isoler et purifier des acides nucleiques
US5990302A (en) * 1996-07-12 1999-11-23 Toyo Boseki Kabushiki Kaisha Method for isolating ribonucleic acid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234809A (en) * 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
US5681946A (en) * 1990-02-13 1997-10-28 Amersham International Plc Precipitating polymers
US5990302A (en) * 1996-07-12 1999-11-23 Toyo Boseki Kabushiki Kaisha Method for isolating ribonucleic acid
EP0897978A2 (fr) * 1997-08-22 1999-02-24 Becton, Dickinson and Company Oxyde de zirconium et de composés apparentés pour la purification des acides nucléiques
WO1999040098A1 (fr) * 1998-02-04 1999-08-12 Merck Patent Gmbh Procede pour isoler et purifier des acides nucleiques

Also Published As

Publication number Publication date
AU2002351787A8 (en) 2003-06-10
DE10157624A1 (de) 2003-06-05
WO2003046213A2 (fr) 2003-06-05
AU2002351787A1 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
WO2001096595A3 (fr) Procede de depistage des virus grippaux a/b
NO996243L (no) Retentatkromatografi og proteinchipsrekker med anvendelse innen biologi og medisin
WO2001060517A3 (fr) Recipient pour l'analyse d'acide nucleique
AU1038402A (en) Assay for directly detecting a rs virus related biological cell in a body fluid sample
WO2004070020A3 (fr) Evenements transgeniques de la luzerne tolerant aux glycophosphates et methodes de detection
WO2003068947A8 (fr) Electrodes de test comportant des couches de lipide/proteine immobilises et procedes de fabrication et d'utilisation associes
WO2004072097A3 (fr) Systeme base sur une puce pour le diagnostic du vih
WO2003064993A3 (fr) Methodes et materiels de detection de materiel genetique
HUP0303134A2 (hu) HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és eljárás HIV által indukált antitestek detektálására
WO2005068628A3 (fr) Procedes d'isolation d'un acide nucleique et trousses utilisant un materiau en phase solide
WO2001044286A3 (fr) Proteine a cinq helices
WO2003086308A3 (fr) Compositions et procedes pour le diagnostic et le traitement de l'infection du virus de l'herpes simplex
WO2001098460A3 (fr) Proteines de fusion du mycobacterium tuberculosis
WO2005047459A3 (fr) Acides nucleiques du sars, proteines, anticorps et utilisations associees
AU2001290579A1 (en) Methods for detecting papillomavirus dna in blood plasma and serum
CA2500407A1 (fr) Dispositifs de diagnostic
WO2003050291A3 (fr) Capteurs utilises dans le test d'echantillons biologiques chimiques ou environnementaux
WO2002012899A3 (fr) Peptides presents par cellules
WO2002038792A3 (fr) Nouvelle methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine (vih)
WO2003046213A3 (fr) Procede pour concentrer et identifier des vih
WO2002002131A3 (fr) Compositions et methodes de diagnostic et de traitement de l'infection du virus de l'herpes
WO2002077012A3 (fr) Peptides immunoreactifs du papillomavirus humain
WO2006127822A3 (fr) Polypeptides associes au domaine 1 de scytovirine
EP1035220A3 (fr) Amorces oligonucléotidiques pour la détection multiplex du virus de l'hépatite C (VHC) et du virus d'immuno-déficience humaine (VIH) et leurs méthodes d'utilisation
AU6329099A (en) Method for purifying or isolating viral nucleic acids

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP